Challenges and controversies in the diagnosis of mesothelioma: Part 1. Cytology-only diagnosis, biopsies, immunohistochemistry, discrimination between mesothelioma and reactive mesothelial hyperplasia, and biomarkers.

Challenges and controversies in the diagnosis of mesothelioma: Part 1. Cytology-only diagnosis, biopsies, immunohistochemistry, discrimination between mesothelioma and reactive mesothelial hyperplasia, and biomarkers.

Item
http://www.wikidata.org/entity/Q38118298
Guidelines for cytopathologic diagnosis of epithelioid and mixed type malignant mesothelioma. Complementary statement from the International Mesothelioma Interest Group, also endorsed by the International Academy of Cytology and the Papanicolaou SocLoss of expression of BAP1 is a useful adjunct, which strongly supports the diagnosis of mesothelioma in effusion cytologyMicroRNAs in mesothelioma: from tumour suppressors and biomarkers to therapeutic targetsGlobal mesothelioma epidemic: Trend and features.Malignant pleural mesothelioma: current and future perspectivesAdvances in treatment of mesothelioma.Pathology analysis for mesothelioma study in the United Kingdom: Current practice and historical development.Patterns in the incidence, mortality and survival of malignant pleural and peritoneal mesothelioma, New South Wales, 1972-2009.Guidelines for the cytopathologic diagnosis of epithelioid and mixed-type malignant mesothelioma: Complementary Statement from the International Mesothelioma Interest Group, Also Endorsed by the International Academy of Cytology and the PapanicolaouGuidelines for the Cytopathologic Diagnosis of Epithelioid and Mixed-Type Malignant Mesothelioma: a secondary publication.A diagnostically difficult case of a cellular pleural fluid: Morphology, immunohistochemistry, and fluorescence in situ hybridization study.Cytologic Differential Diagnosis of Malignant Mesothelioma and Reactive Mesothelial Cells With FISH Analysis of p16.The "don't eat me" signal CD47 is a novel diagnostic biomarker and potential therapeutic target for diffuse malignant mesothelioma.An update on pleuro-pulmonary cytopathology: Part i: Cytological diagnosis of mesothelioma and molecular cytology of lung cancer with an historical perspective.The pathological and molecular diagnosis of malignant pleural mesothelioma: a literature review.
P2860

Challenges and controversies in the diagnosis of mesothelioma: Part 1. Cytology-only diagnosis, biopsies, immunohistochemistry, discrimination between mesothelioma and reactive mesothelial hyperplasia, and biomarkers.

Item
http://www.wikidata.org/entity/Q38118298
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Challenges and controversies i ...... l hyperplasia, and biomarkers.
@en
type
label
Challenges and controversies i ...... l hyperplasia, and biomarkers.
@en
prefLabel
Challenges and controversies i ...... l hyperplasia, and biomarkers.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P698
P921
P356
P1433
P1476
Challenges and controversies i ...... l hyperplasia, and biomarkers.
@en
P2093
P2860
P304
P31
P356
10.1136/JCLINPATH-2012-201303
P407
P433
P478
P50
P577
P698
P921